Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $392.37B.
ENTERPRISE VALUE (EV)
$392.37B
Roche Holding AG
Market Cap
$359.46B
Enterprise Value (EV)
$392.37B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | $392.37B |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | $403.51B |
| Merck & Co., Inc. (MRK)vs › | $369.34B | $419.88B |
| AbbVie Inc. (ABBV)vs › | $455.87B | $519.79B |
| AstraZeneca PLC (AZN)vs › | $255.15B | $283.33B |
| Amgen Inc. (AMGN)vs › | $235.85B | $279.97B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | $272.87B |
| Novo Nordisk A/S (NVO)vs › | $205.42B | $219.91B |
| Abbott Laboratories (ABT)vs › | $193.04B | $221.79B |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | $207.03B |
Market Cap
$359.46B
Total Debt
$39.95B
Cash
$7.05B
Enterprise Value
$392.37B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
